# Therapeutic Goods Administration (TGA)

Type: Company

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/therapeutic-goods-administration-tga
Canonical HTML page: https://getbiobrief.com/entity/therapeutic-goods-administration-tga

## Recent coverage (3 stories)

### Patient Advocacy Signals Growth in Medicinal Cannabis for PTSD Treatment
2026-03-20 23:02:59 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Bilal Cassim’s public testimony regarding the efficacy of medicinal cannabis for PTSD and sleep disorders highlights a growing trend of patient-led advocacy in Australia. This case underscores the shifting clinical landscape as researchers and regulators grapple with the integration of cannabinoid therapies into standard psychiatric care.
Full story: https://getbiobrief.com/story/medicinal-cannabis-ptsd-patient-advocacy-australia

### Lancet Study Challenges Efficacy of Medicinal Cannabis for Mental Health
2026-03-17 00:59:26 · Sentiment: Negative · Impact: 7/10 · Sources: 2

A comprehensive study published in The Lancet concludes that medicinal cannabis is largely ineffective for treating anxiety, depression, and PTSD. These findings challenge the rapidly growing global market for cannabinoid-based mental health treatments and highlight a significant gap between patient perception and clinical evidence.
Full story: https://getbiobrief.com/story/lancet-study-medicinal-cannabis-ineffective-mental-health

### Australia Slashes Subsidies for Spinal Implants Amid Safety Concerns
2026-02-27 09:19:25 · Sentiment: Negative · Impact: 7/10 · Sources: 3

The Australian government is significantly reducing subsidies for high-cost spinal cord stimulators following reports of severe patient injuries and a lack of clinical efficacy. This regulatory shift targets a multi-million dollar sector of the medical device market, forcing manufacturers to justify the high price tags of chronic pain technologies.
Full story: https://getbiobrief.com/story/australia-spinal-implant-subsidy-cuts

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.